englitazone has been researched along with Cataract, Membranous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleo, MD; Doshna, CM; Navetta, KA | 1 |
| Aleo, MD; Avery, MJ; Beierschmitt, WP; Drupa, CA; Fortner, JH; Kaplan, AH; Navetta, KA; Shepard, RM; Walsh, CM | 1 |
2 other study(ies) available for englitazone and Cataract, Membranous
| Article | Year |
|---|---|
Ciglitazone-induced lenticular opacities in rats: in vivo and whole lens explant culture evaluation.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cataract; Dogs; Dose-Response Relationship, Drug; Female; Glutathione; Hypoglycemic Agents; Male; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Thiazolidinediones | 2005 |
The use of explant lens culture to assess cataractogenic potential.
Topics: Adenosine Triphosphate; Aminooxyacetic Acid; Animals; Benzopyrans; Biotransformation; Cataract; Drug-Related Side Effects and Adverse Reactions; Glutathione; Lens, Crystalline; Lipoxygenase Inhibitors; Male; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Toxicity Tests; Xenobiotics | 2000 |